Straumann Holding Ag · SIX:STMN
Straumann — Q3 2014 Earnings Presentation
32 slides from Straumann's earnings presentation, Oct 23, 2014
Slide 1: 2014 Straumann 9-month and third-quarter results
2014 Straumann 9-month and third-quarter results Basel, 23 October 2014 1
Slide 2: Disclaimer
Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Straumann Group to differ m
Slide 3: Highlights
Highlights Marco Gadola, CEO
Slide 4: A new phase in Straumann’s development
A new phase in Straumann’s development After successful restructuring, Straumann is entering a new phase with cultural change and further adaptation to new market realities ■ Dr Sandro Matter, EVP Instradent Management & Strategic Alliances, leaves Straumann after 12 years in various leadership role
Slide 5: Further expansion
Further expansion 9M REVENUE GROWTH REGIONS KEY DRIVERS +5% Growth in all regions Roxolid SLActive 9M: +5% (organic1) +3% (CHF) Double-digit growth in APAC throughout Customers convert from titanium Q3: +7% (organic) +6% (CHF) and in N. America in Q3; Europe solid. implants to Roxolid SLActive, driv
Slide 6: Business and regional review
Business and regional review Thomas Dressendörfer, CFO
Slide 7: Pace quickens
Pace quickens 10% 5% 0% -5% -10% -15% Market for tooth replacement & restoration (leading implant companies)1 Straumann l.c. growth * Straumann, Nobel Biocare, Zimmer Dental, Biomet 3i, Dentsply Implants - based on company and SEC reports as well as management comments. 1Straumann, Nobel Biocare, Zi
Slide 8: All regions contribute to growth
All regions contribute to growth In CHF million, rounded 2.6% in CHF 5.4% in l.c. 3.1 9.5 (13.4) 9.5 4.7 523.4 510.0 496.6 Change in l.c. (2.8%) 1.7% 7.3% 13.8% 13.1% Revenue 9M FX Effect Revenue 9M Europe North America APAC ROW Revenue 9M 2013 2013 @ FX 2014 2014 2013 2014 8
Slide 9: Strong performance in N. America; Europe solid
Strong performance in N. America; Europe solid Revenue change (organic) Europe returns to growth; solid Q3 4.1% (+3%) despite challenging market 2.7% Europe 0.2% 56% environment Scandinavia and the UK continue (1.4%) (1.5%) (3.4%) to post good results 53% Germany posts growth; Swiss Q2 2013 Q3
Slide 10: Boost from emerging markets and Japan
Boost from emerging markets and Japan Revenue change (organic) Dynamic growth driven by China Asia Pacific 16.3% 17.0% 15.3% and Japan 56% 7.9% 8.3% General market recovery continues in Japan 0.9% Bone level SLActive launched in Japan in Q3 15% Q2 2013 Q3 2013 Q4 2013 Q1 2014 Q2 2014 Q3 2014 3
Slide 11: Strong demand for implants and regenerative products offsets softness in prosthetics
Strong demand for implants and regenerative products offsets softness in prosthetics Implants Restorative Regeneratives 11
Slide 12: Q3 highlights – products & solutions update
Q3 highlights – products & solutions update Marco Gadola, CEO
Slide 13: Key events used to launch new products and solutions
Key events used to launch new products and solutions ■ Full regenerative portfolio launched ■ Controlled release of Bone Level Tapered Implant ■ Reduced-diameter (3.3mm) PURE ceramic implant launched EAO: 3500 participants Bone&Tissue Days: 800 participants 13 13
Slide 14: Straumann: a full solution provider with a comprehensive regenerative range
Straumann: a full solution provider with a comprehensive regenerative range Straumann botiss Geistlich Bone allografts 1 Bone xenografts Synthetic bone grafts Bone blocks Custom bone blocks Bone rings Collagen cones Fleeces & sponges Membranes 1 Soft-tissue grafts () Emd
Slide 15: botiss goes Straumann
botiss goes Straumann 15 ff Launch 2014 @ Launch >2014 Z straumann
Slide 16: New membrane and xenograft in North America
New membrane and xenograft in North America Two new products sold under licence to fill portfolio gaps Straumann® Membrane Plus™ ■ Collagen membrane with convenient handling and predictable resorption over 6 months ■ Ideal for larger defects requiring longer healing Straumann® XenoGraft ■ Excellent
Slide 17: New-generation Straumann BLT implant addresses a significant portion of the market
New-generation Straumann BLT implant addresses a significant portion of the market Global implant market by Anticipated growth of the tapered implant implant design (in units)1 segment until 2020 by region 40‐45% 55‐60% 2012 2013 2014 2015 2016 2017 2018 2019 2020 Tapered Parallel‐walled APAC LATAM
Slide 18: Straumann Pro Arch addresses market needs for immediate fixed edentulous solutions
Straumann® Pro Arch™ addresses market needs for immediate fixed edentulous solutions 18 Protocol developed by Dr. P. Malo in mid 90s
Slide 19: Createch prosthetics available to Straumann customers in Europe
Createch prosthetics available to Straumann customers in Europe ■ Createch high-end CADCAM bars and prosthetics are now included in Straumann solutions 19
Slide 20: Botiss and Createch – partners in Straumann’s common platform
Botiss and Createch – partners in Straumann’s common platform for technology & production Broad spectrum of regeneratives to High-precision prosthetics to complement complement implant therapy CADCAM-based restorations 20
Slide 21: Straumann to supply ClearChoice
Straumann to supply ClearChoice ■ ClearChoice Clinical Advisory Board chooses Straumann’s broad range of proven products and cutting-edge technologies ■ Unique Roxolid® SLActive® BLT implant and new prosthetics range important in decision ■ ClearChoice affiliated doctors will also have access to oth
Slide 22: Small-diameter PURE ceramic implant
Small-diameter PURE ceramic implant ■ Designed for metal-free treatments in narrow spaces (e.g. esthetic zone at front of mouth) ■ Complements 4.1mm PURE ceramic implant launched in Q1 ■ Innovative manufacturing process; 100% tested in 360° strength test, setting benchmark in reliability ■ 97.6% cli
Slide 23: Instradent distribution platform expands
Instradent distribution platform expands ■ Instradent/Neodent operations combined in Iberia ■ Instradent subsidiary established in Italy ■ Planned launch of Neodent and Medentika brands early 2015 ■ Italy = world’s 4th largest market for dental implants (by volume) ■ Instradent USA (formerly Neodent
Slide 24: Instradent goes online
Instradent goes online Who are we? Instradent is a global provider of dental implantology and tooth restoration solutions. We represent and distribute a family of products that excel with high quality and competitive prices. What do we do? Instradent offers a broad range of dental implants and prost
Slide 25: Instradent e-shop launched in US
Instradent e-shop launched in US 25
Slide 26: Outlook
straumann simply doing more
Slide 27: Outlook 2014
Outlook 2014 Barring unforeseen circumstances ■ Straumann expects the global implant market to develop positively in 2014. ■ The Group will continue to invest in growth markets and its non-premium offering. ■ Based on its year-to-date performance, it expects full-year revenue to grow in the mid-sing
Slide 28: Questions & Answers
Questions & Answers 28 Z straumann
Slide 29: Calendar of upcoming events
Calendar of upcoming events 2014 23 October Third‐quarter results Webcast 20 November Credit Suisse Swiss Midcap conference Zurich 03 December Berenberg European conference Bagshot/London 04 December Investor meetings London 2015 27 February Full‐year 2014 results Basel HQ 10 April Annual General Me
Slide 30: Straumann’s currency exposure
Straumann’s currency exposure Revenue breakdown 2013 Other Average exchange rates (rounded) FX sensitivity (+/- 10%) on... 20% FY 2013 YTD 2014 Revenue EBIT EUR EURCHF 1.23 1.22 +/- 25 million +/- 15 million 40% USDCHF 0.93 0.91 +/- 17 million +/- 7 million USD / CAD / AUD JPYCHF 0.95 0.88 +/- 4 mil
Slide 31: Your contacts
Your contacts Fabian Hildbrand Corporate Investor Relations Tel. +41 (0)61 965 13 27 Email investor.relations@straumann.com Mark Hill Thomas Konrad Corporate Communications Tel. +41 (0)61 965 13 21 Tel. +41 (0)61 965 15 46 Email mark.hill@straumann.com Email thomas.konrad@straumann.com 31
Slide 32: International Headquarters
International Headquarters Institut Straumann AG Peter Merian-Weg 12 CH-4002 Basel, Switzerland Phone +41(0)61 965 11 11 Fax +41(0)61 965 10 01 www.straumann.com